Dietary Fructooligosaccharides and Potential Benefits on Health
Overview
Physiology
Authors
Affiliations
Fructooligosaccharides (FOS) are oligosaccharides that occur naturally in plants such as onion, chicory, garlic, asparagus, banana, artichoke, among many others. They are composed of linear chains of fructose units, linked by beta (2-1) bonds. The number of fructose units ranges from 2 to 60 and often terminate in a glucose unit. Dietary FOS are not hydrolyzed by small intestinal glycosidases and reach the cecum structurally unchanged. There, they are metabolized by the intestinal microflora to form short-chain carboxylic acids, L -lactate, CO(2), hydrogen and other metabolites. FOS have a number of interesting properties, including a low sweetness intensity; they are also calorie free, non-cariogenic and are considered as soluble dietary fibre. Furthermore, FOS have important beneficial physiological effects such as low carcinogenicity, a prebiotic effect, improved mineral absorption and decreased levels of serum cholesterol, triacylglycerols and phospholipids. Currently FOS are increasingly included in food products and infant formulas due to their prebiotic effect stimulate the growth of nonpathogenic intestinal microflora. Their consumption increases fecal bolus and the frequency of depositions, while a dose of 4-15 g/day given to healthy subjects will reduce constipation, considered one of the growing problems of modern society, and newborns during the first months of life.
Gorrepati K, Krishna R, Singh S, Shirsat D, Soumia P, Mahajan V Front Nutr. 2024; 11:1497953.
PMID: 39610875 PMC: 11602312. DOI: 10.3389/fnut.2024.1497953.
Harnessing Prebiotics to Improve Type 2 Diabetes Outcomes.
Iatcu O, Hamamah S, Covasa M Nutrients. 2024; 16(20).
PMID: 39458444 PMC: 11510484. DOI: 10.3390/nu16203447.
Santamarina A, Filho V, de Freitas J, Franco L, Fonseca J, Martins R Nutrients. 2024; 16(18).
PMID: 39339649 PMC: 11435014. DOI: 10.3390/nu16183049.
Mechanisms of action and applications of polysaccharide at the intestinal mucosa barrier: a review.
Ren Y, Sun Y, Liao Y, Wang S, Liu Q, Duan C Front Pharmacol. 2024; 15:1421607.
PMID: 39224782 PMC: 11366640. DOI: 10.3389/fphar.2024.1421607.
Hanson T, Constantine E, Nobles Z, Butler E, Renteria K, Teoh C Nutrients. 2024; 16(14).
PMID: 39064679 PMC: 11280458. DOI: 10.3390/nu16142236.